Annual SG&A
$343.33 M
+$45.03 M+15.10%
31 December 2023
Summary:
10x Genomics annual selling, general & administrative expenses is currently $343.33 million, with the most recent change of +$45.03 million (+15.10%) on 31 December 2023. During the last 3 years, it has risen by +$141.00 million (+69.69%). TXG annual SG&A is now at all-time high.TXG Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$81.70 M
-$1.33 M-1.61%
30 September 2024
Summary:
10x Genomics quarterly selling, general & administrative expenses is currently $81.70 million, with the most recent change of -$1.33 million (-1.61%) on 30 September 2024. Over the past year, it has dropped by -$711.00 thousand (-0.86%). TXG quarterly SG&A is now -10.72% below its all-time high of $91.51 million, reached on 30 June 2023.TXG Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$5.43 B
-$182.55 M-3.48%
30 September 2024
Summary:
10x Genomics TTM selling, general & administrative expenses is currently -$5.43 billion, with the most recent change of -$182.55 million (-3.48%) on 30 September 2024. Over the past year, it has dropped by -$5.77 billion (-1715.35%). TXG TTM SG&A is now -718.27% below its all-time high of $345.82 million, reached on 31 March 2024.TXG TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.1% | -0.9% | -1715.3% |
| 3 y3 years | +69.7% | +31.6% | -2328.2% |
| 5 y5 years | +290.4% | +150.5% | -4662.9% |
TXG Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +69.7% | -10.7% | +31.6% | -64.8% | at low |
| 5 y | 5 years | at high | +290.4% | -10.7% | +150.5% | -641.7% | at low |
| alltime | all time | at high | +634.6% | -10.7% | +327.6% | -718.3% | at low |
10x Genomics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $81.70 M(-1.6%) | $336.64 M(-0.2%) |
| June 2024 | - | $83.04 M(-3.2%) | $337.35 M(-2.4%) |
| Mar 2024 | - | $85.77 M(-0.4%) | $345.82 M(+0.7%) |
| Dec 2023 | $343.33 M(+15.1%) | $86.13 M(+4.5%) | $343.33 M(+2.2%) |
| Sept 2023 | - | $82.42 M(-9.9%) | $336.09 M(+2.8%) |
| June 2023 | - | $91.51 M(+9.9%) | $327.08 M(+3.9%) |
| Mar 2023 | - | $83.28 M(+5.6%) | $314.90 M(+5.6%) |
| Dec 2022 | $298.30 M(+15.8%) | $78.89 M(+7.5%) | $298.30 M(+3.1%) |
| Sept 2022 | - | $73.40 M(-7.5%) | $289.29 M(+4.1%) |
| June 2022 | - | $79.34 M(+19.0%) | $277.96 M(+4.0%) |
| Mar 2022 | - | $66.67 M(-4.6%) | $267.33 M(+3.8%) |
| Dec 2021 | $257.56 M | $69.88 M(+12.6%) | $257.56 M(+5.7%) |
| Sept 2021 | - | $62.08 M(-9.6%) | $243.66 M(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $68.70 M(+20.7%) | $233.13 M(+11.6%) |
| Mar 2021 | - | $56.90 M(+1.7%) | $208.84 M(+3.2%) |
| Dec 2020 | $202.33 M(+54.6%) | $55.97 M(+8.6%) | $202.33 M(+9.3%) |
| Sept 2020 | - | $51.55 M(+16.1%) | $185.11 M(+11.4%) |
| June 2020 | - | $44.42 M(-11.9%) | $166.17 M(+7.7%) |
| Mar 2020 | - | $50.39 M(+30.0%) | $154.33 M(+18.0%) |
| Dec 2019 | $130.83 M(+48.8%) | $38.76 M(+18.8%) | $130.83 M(+10.0%) |
| Sept 2019 | - | $32.61 M(+0.1%) | $118.98 M(+12.8%) |
| June 2019 | - | $32.57 M(+21.1%) | $105.48 M(+44.7%) |
| Mar 2019 | - | $26.89 M(-0.0%) | $72.91 M(+58.4%) |
| Dec 2018 | $87.94 M(+88.2%) | $26.91 M(+40.8%) | $46.02 M(+140.8%) |
| Sept 2018 | - | $19.11 M | $19.11 M |
| Dec 2017 | $46.74 M | - | - |
FAQ
- What is 10x Genomics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for 10x Genomics?
- What is 10x Genomics annual SG&A year-on-year change?
- What is 10x Genomics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for 10x Genomics?
- What is 10x Genomics quarterly SG&A year-on-year change?
- What is 10x Genomics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for 10x Genomics?
- What is 10x Genomics TTM SG&A year-on-year change?
What is 10x Genomics annual selling, general & administrative expenses?
The current annual SG&A of TXG is $343.33 M
What is the all time high annual SG&A for 10x Genomics?
10x Genomics all-time high annual selling, general & administrative expenses is $343.33 M
What is 10x Genomics annual SG&A year-on-year change?
Over the past year, TXG annual selling, general & administrative expenses has changed by +$45.03 M (+15.10%)
What is 10x Genomics quarterly selling, general & administrative expenses?
The current quarterly SG&A of TXG is $81.70 M
What is the all time high quarterly SG&A for 10x Genomics?
10x Genomics all-time high quarterly selling, general & administrative expenses is $91.51 M
What is 10x Genomics quarterly SG&A year-on-year change?
Over the past year, TXG quarterly selling, general & administrative expenses has changed by -$711.00 K (-0.86%)
What is 10x Genomics TTM selling, general & administrative expenses?
The current TTM SG&A of TXG is -$5.43 B
What is the all time high TTM SG&A for 10x Genomics?
10x Genomics all-time high TTM selling, general & administrative expenses is $345.82 M
What is 10x Genomics TTM SG&A year-on-year change?
Over the past year, TXG TTM selling, general & administrative expenses has changed by -$5.77 B (-1715.35%)